These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4377336)

  • 1. [Role of amino acids in the formaldehyde inactivation of the foot-and-mouth disease virus].
    Ulupov NA
    Veterinariia; 1974 Sep; (9):38-9. PubMed ID: 4377336
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative resistance of foot-and-mouth disease virus to formalin and hydroxylamine].
    Nikitin EE; Uziumov VL; Kravchenko AA; Muliar MA; Romanenko MA
    Veterinariia; 1968 May; 45(5):21-2. PubMed ID: 4314302
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological behaviour & antigenicity of mouse passaged & formol inactivated foot & mouth disease virus type Asia-1 in guineapigs.
    Saraswat KC; Sharma KN; Mehrotra PN
    Indian J Exp Biol; 1980 Mar; 18(3):275-8. PubMed ID: 6248457
    [No Abstract]   [Full Text] [Related]  

  • 4. Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine.
    Barteling SJ; Woortmeyer R
    Arch Virol; 1984; 80(2-3):103-17. PubMed ID: 6326708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of foot-and-mouth disease virus by heat, formaldehyde, ethylene oxide and gamma radiation.
    Dekker A
    Vet Rec; 1998 Aug; 143(6):168-9. PubMed ID: 9746947
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inactivation of the foot-and-mouth disease virus by methylglyoxal].
    Amfiteatrov FZ; Gizatullina NK; Vasiunin VM
    Veterinariia; 1973 May; 49(5):64-5. PubMed ID: 4353689
    [No Abstract]   [Full Text] [Related]  

  • 7. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ; Cassim NI
    Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditions for proper formaldehyde inactivation of foot and mouse disease alhydrogel vaccines.
    Barteling SJ
    Dev Biol Stand; 1985; 60():323-9. PubMed ID: 2995172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the inactivation and antigenicity of foot-and-mouth-disease virus by acetylethyleneimine and by combined effect of ultraviolet light and beta-propiolactone.
    Fellowes ON
    J Immunol; 1965 Dec; 95(6):1100-6. PubMed ID: 4285068
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure.
    Wild TF; Brown F
    Arch Gesamte Virusforsch; 1968; 24(1):86-103. PubMed ID: 4301974
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivation of antibody-neutralized foot-and-mouth disease virus by organic chemicals and inhibition by 1-butanol.
    Tessler J
    Am J Vet Res; 1966 Jul; 27(119):917-22. PubMed ID: 4290880
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of 1 mol MgC12 and 2 mol NaC1 on the inactivation at 50 degrees C of foot-and-mouth disease virus (MKS)].
    Wittmann G
    Zentralbl Bakteriol Orig; 1967 Jan; 202(1):133-4. PubMed ID: 4300049
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inactivation of foot-and-mouth disease virus with special consideration of tenacity and disinfection].
    Wittmann G
    Schweiz Arch Tierheilkd; 1967 Jun; 109(6):313-23. PubMed ID: 4300478
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative testing of the quality of foot-and-mouth disease vaccines prepared with different virus inactivators].
    Dilovski M; Tekerlekov P
    Vet Med Nauki; 1983; 20(5-6):41-5. PubMed ID: 6318423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenically profound amino acid substitutions occur during large population passages of foot-and-mouth disease virus.
    Sevilla N; Verdaguer N; Domingo E
    Virology; 1996 Nov; 225(2):400-5. PubMed ID: 8918927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
    [No Abstract]   [Full Text] [Related]  

  • 18. The inactivation of foot-and mouth disease virus by chemicals and disinfectants.
    Sellers RF
    Vet Rec; 1968 Nov; 83(20):504-6. PubMed ID: 4301329
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the immunogenic capacity of the foot-and-mouth disease virus by measurement of complement fixing capacity after treatment by a fluorocarbon].
    Roumiantzeff M; Fontaine J; Dubouclard C
    C R Acad Hebd Seances Acad Sci D; 1965 Jul; 261(2):598-601. PubMed ID: 4285035
    [No Abstract]   [Full Text] [Related]  

  • 20. Actinomycetes activity against foot and mouth disease virus determined by a new method.
    De Banchero EP; Goyena JG; Cercos AP
    J Antibiot (Tokyo); 1965 Jul; 18(4):195. PubMed ID: 4285352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.